Leadership

Andrew is the Founder and CEO of Renthera. Andrew also serves as the Chief Investment Officer at Gödel Escher which focuses on pharmaceutical and biotechnology investments. Prior to Renthera, Andrew managed the Global Macro Portfolio at Blue Creek Asset Management in Hong Kong in addition to leading the Quantitative and Derivatives Strategy team. Andrew studied Molecular Biology at Georgetown University and postgraduate Mathematical and Computational Finance at Oriel College at Oxford University. 

Suzie taught molecular sciences at Fudan University and was a senior computational geneticist at Xinghua Biomedical before Renthera.  She also served as Assistant Director of the Tumor Biotherapy Laboratory at ZhongShan Hospital, Fudan University, for six years. She earned her doctorate of Philosophy in Cell Physiology from Osaka University in Japan. 

R.C. Chai , Sai,  has a Masters of Science from the University of Texas at Austin in Electrical and Computer Engineering. Before joining Renthera,  Sai was an ASICS engineer at NVDIIA and Senior Design Engineer at Qualcomm.